Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.07
- Piotroski Score 4.00
- Grade Equal-Weight
- Symbol (FTRE)
- Company Fortrea Holdings Inc.
- Price $18.85
- Changes Percentage (-2.53%)
- Change -$0.49
- Day Low $18.66
- Day High $19.51
- Year High $41.02
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/10/2025
- Fiscal Year End N/A
- Average Stock Price Target $28.00
- High Stock Price Target $36.50
- Low Stock Price Target $22.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.02
- Trailing P/E Ratio -25.99
- Forward P/E Ratio -25.99
- P/E Growth -25.99
- Net Income $-3,400,000
